PARSIPPANY, N.J., Aug. 13, 2012 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the second quarter ended June 30, 2012. Summary of second quarter and subsequent financial and operating highlights include:
- Second quarter 2012 operating loss from continuing operations of $0.3 million improved 70% compared to a loss of $1.1 million during the second quarter of 2011.
- Second quarter adjusted EBITDA was $0.8 million compared to $0.1 million in the same period of 2011.
- Since the midpoint of the second quarter, announced new business wins, renewals and extensions expected to generate total combined revenues of approximately $102 million, with a projected $33 million to $35 million to be recorded in 2012, primarily in the second half. Wins included contracts with two, new top 10 global pharmaceutical companies and a number of new, mid-sized pharmaceutical companies.
